메뉴 건너뛰기




Volumn 110, Issue 8, 2007, Pages 2786-2787

Endostatin finds a new partner: Nucleolin

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; CANSTATIN; ENDOSTAR; ENDOSTATIN; NUCLEOLIN; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 1; TUMSTATIN; UNCLASSIFIED DRUG;

EID: 35548930342     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-08-102178     Document Type: Note
Times cited : (15)

References (10)
  • 1
    • 33947732977 scopus 로고    scopus 로고
    • Angiogenesis: An organizing principle for drug discovery?
    • Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6:273-286.
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 273-286
    • Folkman, J.1
  • 2
    • 57749092969 scopus 로고    scopus 로고
    • Davis DW, Herbst RS, Abbruzzese JL, eds, Boca Raton, FL: CRC;
    • Davis DW, Herbst RS, Abbruzzese JL, eds. Antiangiogenic Cancer Therapy. Boca Raton, FL: CRC; 2008.
    • (2008) Antiangiogenic Cancer Therapy
  • 4
    • 20144379162 scopus 로고    scopus 로고
    • Endogenous inhibitors of angiogenesis
    • Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res. 2005;10:3967-3979.
    • (2005) Cancer Res , vol.10 , pp. 3967-3979
    • Nyberg, P.1    Xie, L.2    Kalluri, R.3
  • 5
    • 1642307340 scopus 로고    scopus 로고
    • Endostatin's antiangiogenic signaling network
    • Abdollahi A, Hahnfeldt P, Maercker C, et al. Endostatin's antiangiogenic signaling network. Mol Cell. 2004;13:649-663.
    • (2004) Mol Cell , vol.13 , pp. 649-663
    • Abdollahi, A.1    Hahnfeldt, P.2    Maercker, C.3
  • 6
    • 28244462515 scopus 로고    scopus 로고
    • Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve
    • Celik I, Surucu O, Dietz C, et al. Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. Cancer Res. 2005;65:11044-11050.
    • (2005) Cancer Res , vol.65 , pp. 11044-11050
    • Celik, I.1    Surucu, O.2    Dietz, C.3
  • 7
    • 0032719528 scopus 로고    scopus 로고
    • Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule
    • Slaton JW, Perrotte P, Inoue K, Dinney CP, Fidler IJ. Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. Clin Cancer Res. 1999;5:2726-2734.
    • (1999) Clin Cancer Res , vol.5 , pp. 2726-2734
    • Slaton, J.W.1    Perrotte, P.2    Inoue, K.3    Dinney, C.P.4    Fidler, I.J.5
  • 8
    • 33747619857 scopus 로고    scopus 로고
    • p53-mediated inhibition of angiogenesis through upregulation of a collagen prolyl hydroxylase
    • Teodoro JG, Parker AE, Zhu X, Green MR. p53-mediated inhibition of angiogenesis through upregulation of a collagen prolyl hydroxylase. Science. 2006;313:968-971.
    • (2006) Science , vol.313 , pp. 968-971
    • Teodoro, J.G.1    Parker, A.E.2    Zhu, X.3    Green, M.R.4
  • 9
    • 34247856977 scopus 로고    scopus 로고
    • Folkman J. Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin. Sci STKE. 2006;354:pe35.
    • Folkman J. Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin. Sci STKE. 2006;354:pe35.
  • 10
    • 25844486122 scopus 로고    scopus 로고
    • Endostatin inhibits the growth of endometriotic lesions but does not affect fertility
    • Becker CM, Sampson DA, Rupnick MA, et al. Endostatin inhibits the growth of endometriotic lesions but does not affect fertility. Fertil Steril. 2005;84:1144-1155.
    • (2005) Fertil Steril , vol.84 , pp. 1144-1155
    • Becker, C.M.1    Sampson, D.A.2    Rupnick, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.